Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.65 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.65 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.60 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.58 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.58 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.58 |
| ▸ | MKNK2 | Q9HBH9 | 1/20 | 0.58 |
| ▸ | MAP4K5 | Q9Y4K4 | 1/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.55 |
| ▸ | FEN1 | P39748 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.54 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.54 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29446517 | 1.00 | KMO (0.67) | KMOMAPTSMN1; SMN2HDAC8MAP4K4 | |
| SCHEMBL2586835 | 0.96 | KMO (0.59) | KMOMAPTSMN1; SMN2HDAC8MAP4K4 | |
| SCHEMBL10389918 | 0.93 | MAP4K4 (0.59) | KMOMAPTSMN1; SMN2HDAC8MAP4K4 | |
| SCHEMBL10389377 | 0.89 | MAPT (0.69) | KMOMAPTSMN1; SMN2MAP4K4CSNK1G2 | |
| SCHEMBL29951818 | 0.89 | KMO (0.70) | KMOMAPTSMN1; SMN2MAP4K4CSNK1G2 | |
| SCHEMBL3015814 | 0.89 | KMO (0.70) | KMOMAPTSMN1; SMN2MAP4K4CSNK1G2 | |
| Acetophenone SCHEMBL27984785 | 0.89 | MAPT (0.68) | KMOMAPTSMN1; SMN2HDAC8MAP4K4 | |
| SCHEMBL2943938 | 0.88 | KMO (0.63) | KMOMAPTSMN1; SMN2HDAC2KMT2A | |
| Biphenyl SCHEMBL1555184 | 0.86 | MAPT (0.86) | KMOMAPTSMN1; SMN2HDAC2LMNA | |
| SCHEMBL4572428 | 0.86 | NPC1 (0.56) | KMOMAPTSMN1; SMN2MAP4K4CSNK1G2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 192 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4464696-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD FOR PREPARING SAME, EPOXY COMPOSITE MATERIAL COMPRISING SAME, AND DECOMPOSITION METHOD THEREOF | Konkuk University Industrial Cooperation Corp. (KR) | 2024-11-20 | — | — | EP | claimed |
| US-20230365742-A1 | CHEMICALLY DEGRADABLE EPOXY COMPOUND, METHOD OF PREPARING SAME COMPOUND, EPOXY COMPOSITE MATERIAL CONTAINING SAME COMPOUND, AND METHOD OF DEGRADING SAME COMPOSITE MATERIAL | KONKUK UNIVERSITY INDUSTRIAL COOPERATION CORP (KR) | 2023-11-16 | — | — | US | claimed |
| CN-106117113-A | Polysubstituted carbazole, derivant and synthetic method thereof | 湘潭大学 | 2016-11-16 | — | — | CN | claimed |
| CN-106046281-A | FUNCTIONALIZED KETONE-ALDEHYDE CONDENSATION RESINS | 赢创德固赛有限公司 | 2016-10-26 | — | — | CN | claimed |
| EP-2785754-B1 | PHOTOACTIVE RESINS, RADIATION CURABLE COMPOSITIONS AND RADIATION CURABLE INKS | SUN CHEMICAL CORP (US) | 2016-07-06 | — | — | EP | claimed |
| US-20140315002-A1 | PHOTOACTIVE RESINS, RADIATION CURABLE COMPOSITIONS AND RADIATION CURABLE INKS | SUN CHEMICAL CORPORATION (US) | 2014-10-23 | — | — | US | claimed |
| EP-2785754-A1 | PHOTOACTIVE RESINS, RADIATION CURABLE COMPOSITIONS AND RADIATION CURABLE INKS | Sun Chemical Corporation (US) | 2014-10-08 | — | — | EP | claimed |
| WO-2013082262-A1 | PHOTOACTIVE RESINS, RADIATION CURABLE COMPOSITIONS AND RADIATION CURABLE INKS | SUN CHEMICAL CORPORATION (US) | 2013-06-06 | — | — | WO | claimed |
| EP-4712750-A2 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | Idemitsu Kosan Co.,Ltd. (JP) | 2026-03-18 | — | — | EP | disclosed |
| US-20250230167-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2025-07-17 | — | — | US | disclosed |
| US-12312317-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2025-05-27 | — | — | US | disclosed |
| CN-119998272-A | Methanogen inhibitors | 阿格里泽伦茨有限合伙公司 | 2025-05-13 | — | — | CN | disclosed |
| CN-115052872-B | Compound, material for organic electroluminescent element, and electronic device | 出光兴产株式会社 | 2025-02-18 | — | — | CN | disclosed |
| CN-113825735-B | Carbon-carbon bond formation method | 奥加诺株式会社 | 2025-01-07 | — | — | CN | disclosed |
| US-4256758-A | 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase | MERCK & CO., INC. (US) | 1981-03-17 | — | — | US | disclosed |
| EP-0021228-A1 | 4-Substituted-3-hydroxy-3-pyrroline-2,5-dione compounds, process for their preparation and pharmaceutical compositions containing the same | MERCK & CO. INC. (US) | 1981-01-07 | — | — | EP | disclosed |
| US-4226887-A | P-BIPHENYLYLACETYLENE | ELI LILLY AND COMPANY (US) | 1980-10-07 | — | — | US | disclosed |
| US-3991212-A | PHENYLACETYLENE COMPOUNDS | ELI LILLY AND COMPANY (US) | 1976-11-09 | — | — | US | disclosed |
| US-3968251-A | Arylacetylene compounds as antithrombotic agents | ELI LILLY AND COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3939278-A | Phenoxyphenyl-acetylenes and thio analogues thereof as antithrombotic agents | ELI LILLY AND COMPANY (US) | 1976-02-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250230167-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, LEF1, L1CAM | KMO 3797/4885MAPT 1646/4885SMN1; SMN2 2652/4885 |
| US-12312317-B2 | Compound, material for organic electroluminescent elements, organic electroluminescent element, and electronic device | PIEZO1, LEF1, L1CAM | KMO 3772/4885MAPT 1595/4885SMN1; SMN2 2672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.